Registered entities
Biontech Ag
Reg. No. HRB48720Germany
BioNTech SE
Reg. No. 1776985United States
BIONTECH USA HOLDING LLC
Reg. No. 364930904United States
Web presence
Audience by country — top 5 markets by share of visits.
| Country | Share |
|---|---|
| Germany | 39.8% |
| United States | 21.8% |
| United Kingdom | 19.9% |
| India | 2.1% |
| Australia | 2% |
Social engagement
Social engagement: 299.1K social following, 2 posts in the last 12 months — below the industry typical range.
Investor mix
30 investors on record; lead investors include Redmile Group, Fidelity Investments, Pfizer Venture Investments, MIG Fonds.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 13 | 43% |
| Private equity | 4 | 13% |
| Bank & private debt | 1 | 3% |
| Other / undisclosed | 12 | 40% |
Share of voice
Share of voice in Germany: 99.2% of web traffic across its competitive set; worldwide: 36.5%.
Recent activity
15 Jun 2026
Partnership
Victorian Government agency mRNA Victoria
24 Mar 2026
Event
European Lung Cancer Congress (ELCC2026)
